Sponsor
Cantex Pharmaceuticals Inc.
1792 Bell Tower Lane Suite 222, 33326-3682, United States
About the sponsor
Cantex Pharmaceuticals Inc. is involved in clinical research focused on glioblastoma, with attention to treatment strategies for patients with newly diagnosed disease and the need for improved brain cancer therapies.
- Central nervous system oncology
- Glioblastoma treatment
- Neuro-oncology
The sponsor’s research activity is centered on combining targeted therapeutic approaches with established radiation therapy and temozolomide-based care in the oncology setting.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.